Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free ESLA Stock Alerts

Estrella Immunopharma (ESLA) Institutional Ownership

Estrella Immunopharma logo
$1.21 +0.01 (+0.75%)
As of 01:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Estrella Immunopharma (NASDAQ:ESLA)

Current
Institutional Ownership
Percentage
0.35%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$412.02K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$63.25K
Get ESLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Estrella Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ESLA Institutional Buying and Selling by Quarter

Estrella Immunopharma Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Renaissance Technologies LLC62,795$67K0.0%-48.7%0.147%
2/18/2026XTX Topco Ltd49,472$77K0.0%+376.9%0.131%
2/18/2026Quadrature Capital Ltd27,781$43K0.0%N/A0.074%
2/13/2026Marshall Wace LLP56,236$88K0.0%N/A0.149%
2/13/2026State Street Corp43,252$67K0.0%+93.5%0.115%
2/12/2026Renaissance Technologies LLC122,468$191K0.0%+1,045.7%0.324%
2/9/2026Geode Capital Management LLC109,808$171K0.0%+8.2%0.291%
2/12/2025Geode Capital Management LLC93,418$106K0.0%+22.0%0.258%
2/13/2024ATW Spac Management LLC40,000$44K0.1%N/A0.114%


ESLA Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Estrella Immunopharma shares: Geode Capital Management LLC ($171K), Marshall Wace LLP ($88K), XTX Topco Ltd ($77K), Renaissance Technologies LLC ($67K), and State Street Corp ($67K), Quadrature Capital Ltd ($43K).Learn more on Estrella Immunopharma's institutional investors.

0.35% of Estrella Immunopharma's stock is owned by institutional investors. Learn more on ESLA's institutional investor holdings.

The following institutional investors have purchased Estrella Immunopharma's stock in the last 24 months: Renaissance Technologies LLC ($111.78K), Marshall Wace LLP ($56.24K), XTX Topco Ltd ($39.10K), Quadrature Capital Ltd ($27.78K), Geode Capital Management LLC ($25.18K), and State Street Corp ($20.90K).

Institutional investors have bought a total of 264,113 shares in the last 24 months. This purchase volume represents approximately $412.02K in transactions.

The following institutional investors have sold Estrella Immunopharma stock in the last 24 months: Renaissance Technologies LLC ($59.67K).

Institutional investors have sold a total of 59,673 shares in the last 24 months. This volume of shares sold represents approximately $63.25K in transactions.


Related Companies

This page (NASDAQ:ESLA) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel